Eva Dahlen
9Patents
2h-index
18Co-inventors
44Inventor score
Filing activity: May 1, 2008 → Sep 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9676862B2 | Anti-CD40 antibodies and methods of treating cancer | Chemistry; Metallurgy | 8 | Active |
| US8303945B2 | Mutants of interleukin-1 receptor antagonist | Chemistry; Metallurgy | 5 | Active |
| US11008396B2 | Polypeptides | Chemistry; Metallurgy | 2 | Active |
| US9834589B2 | CD86 variants with improved affinity for CTLA-4 | Physics | 0 | Active |
| US10640567B2 | Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells | Chemistry; Metallurgy | 0 | Active |
| US12173082B2 | Bispecific polypeptides against CD137 | Chemistry; Metallurgy | 0 | Active |
| US10774150B2 | Polypeptides | Chemistry; Metallurgy | 0 | Active |
| US9163072B2 | Mutants of interleukin-1 receptor antagonist | Chemistry; Metallurgy | 0 | Active |
| US11780928B2 | Polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.